Emad Rizk, M.D., joined Cotiviti (formerly Verscend Technologies) in August 2016 as President and Chief Executive Officer, bringing a 30-year, well-documented track record of delivering improved quality and financial performance to healthcare organizations through forward-thinking leadership, business acumen, and clinical expertise.
With his extensive experience working with payers, hospital systems, government, physicians, and pharmaceutical companies, Dr. Rizk has brought focus and rigor to Cotiviti’s healthcare analytics and technology offerings, positioning the organization for significant growth. Notably, under Dr. Rizk’s leadership, Verscend Technologies completed a $4.9 billion acquisition of Cotiviti Holdings, the largest payer analytics acquisition of 2018. He also oversaw the acquisition of new quality improvement and fraud, waste, and abuse solutions from General Dynamics Information Technology, giving the company the largest and most comprehensive set of quality measures in the payer analytics space.
Prior to joining Cotiviti, Dr. Rizk served as President and Chief Executive Officer of Accretive Health and as a member of its board of directors, where he completed the restatement, restructuring, and repositioning of the company’s offerings and led its profitability to quadruple during his tenure. Prior to Accretive Health, Dr. Rizk was President of McKesson Health Solutions, where he grew the company’s healthcare payer business to one of the largest and most significant leaders in healthcare analytics. Before joining McKesson, Dr. Rizk served as Senior Partner and Global Director for Deloitte Consulting, leading the company’s medical cost and quality management practice across all segments, and Worldwide Medical Director for Monsanto Corporation.
Dr. Rizk serves on boards across the country and well as on the Healthcare Leadership Council, a coalition of chief executives across the entire industry that works to bring affordable and high-quality healthcare to all Americans through the growth of health information technology and reforming payment. He is also currently a Director with the National Alliance for Hispanic Health, a Senior Scholar at Jefferson Medical College, and an editorial board member of Managed Care magazine. Dr. Rizk has also previously held advisory roles with Intarcia Therapeutics, Accuray, the Care Continuum Alliance, University of Miami, University of North Texas, the National Clinical Advisory Board, and the National Quality Review Board.
Well recognized by the industry, Dr. Rizk has been named by Modern Healthcare numerous times as one of the “50 Most Influential Physician Executives in the United States” as well as the “Top 100 Most Powerful People in Healthcare.” Additionally, Managed Healthcare Executive named him to its “Top 25 Leaders in Disease Management.” He is a lecturer at Wharton, Harvard, MIT, Columbia, and the Kellogg School of Management. Dr. Rizk’s is the author of The New Era of Healthcare: Practical Strategies for Providers and Payers. His work has also been widely published in healthcare business publications and medical journals.
Healthcare Finance News: Tufts Health Plan expands telehealth amid Harvard Pilgrim merger
Health Leaders: Healthcare Leaders Reflect on Major Trends in 2019
Integrated Healthcare Executive: How AI use impacts the entire care team
AI in Healthcare: Bipartisan Policy Center hosts public event on the future of AI
Managed Healthcare Executive: The future of healthcare leadership
Becker's Healthcare Podcast: Scott Becker interviews Dr. Emad Rizk
AJMC Managed Care Cast: Addressing the complexities of value-based payment models
Healthcare Finance News: Addressing value-based care's data problem
Modern Healthcare: The power of data in driving transformative innovation
First Report Managed Care: How consumers, employers, and the government are driving payer-provider collaboration
Managed Healthcare Executive: Tools that promote payer-provider collaboration
2020 Health Care Forecast Conference – February 20–21 – Irvine, CA - Learn more